Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

72.15
-2.0900-2.82%
Post-market: 72.150.00000.00%17:50 EDT
Volume:1.95M
Turnover:141.16M
Market Cap:11.92B
PE:-30.32
High:74.05
Open:74.00
Low:71.87
Close:74.24
52wk High:86.74
52wk Low:23.95
Shares:165.19M
Float Shares:164.00M
Volume Ratio:0.70
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3800
EPS(LYR):-2.3812
ROE:-70.80%
ROA:-7.31%
PB:24.37
PE(LYR):-30.30

Loading ...

Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market

Benzinga
·
Mar 27

Ionis Pharmaceuticals price target raised to $106 from $95 at Barclays

TIPRANKS
·
Mar 26

Barclays Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Mar 26

U.S. RESEARCH ROUNDUP- Equitable Holdings, Robinhood Markets, Wingstop

Reuters
·
Mar 26

Ionis Pharmaceuticals Inc : Jefferies Raises Target Price to $113 From $96

THOMSON REUTERS
·
Mar 26

Ionis Pharmaceuticals price target raised to $83 from $77 at Stifel

TIPRANKS
·
Mar 25

Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Mar 25

Ionis Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 25

Ionis Pharmaceuticals price target raised to $120 from $110 at H.C. Wainwright

TIPRANKS
·
Mar 25

Ionis Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $120 From $110

THOMSON REUTERS
·
Mar 25

Camp4 appoints Michael MacLean to board, expands board to nine directors

Reuters
·
Mar 24

Ionis EVP Eugene Schneider disposes of USD 412,000 in common shares

Reuters
·
Mar 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS), GE Healthcare Technologies Inc (GEHC) and Insmed (INSM)

TIPRANKS
·
Mar 24

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live
·
Mar 23

FDA accepts Ionis zilganersen NDA for Priority Review in Alexander disease

Reuters
·
Mar 23

Ionis Announces Zilganersen New Drug Application for Alexander Disease (Axd) Accepted by FDA for Priority Review

THOMSON REUTERS
·
Mar 23

Ionis Pharmaceuticals Inc - Pdufa Target Action Date for Zilganersen Set for September 22, 2026

THOMSON REUTERS
·
Mar 23

Ionis EVP Finance and CFO Elizabeth L. Hougen disposes of USD 16.33 million in common shares

Reuters
·
Mar 19

Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS

TIPRANKS
·
Mar 13

Ionis EVP and Chief Global Product Strategy Officer Kyle Jenne Disposes of Common Shares

Reuters
·
Mar 12